Nicole M Poole1,2, Daniel J Shapiro3, Katherine E Fleming-Dutra4, Lauri A Hicks4, Adam L Hersh5, Matthew P Kronman1. 1. Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, Washington. 2. Seattle Children's Research Institute, Seattle, Washington. 3. Boston Combined Residency Program in Pediatrics, Boston Children's Hospital, Boston, Massachusetts. 4. Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, Georgia; and. 5. Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah.
Abstract
: media-1vid110.1542/5972296744001PEDS-VA_2018-1056Video Abstract OBJECTIVES: To characterize and compare ambulatory antibiotic prescribing for children in US pediatric and nonpediatric emergency departments (EDs). METHODS: A cross-sectional retrospective study of patients aged 0 to 17 years discharged from EDs in the United States was conducted by using the 2009-2014 National Hospital Ambulatory Medical Care Survey ED data. We estimated the proportion of ED visits resulting in antibiotic prescriptions, stratified by antibiotic spectrum, class, diagnosis, and ED type ("pediatric" defined as >75% of visits by patients aged 0-17 years, versus "nonpediatric"). Multivariable logistic regression was used to determine factors independently associated with first-line, guideline-concordant prescribing for acute otitis media, pharyngitis, and sinusitis. RESULTS: In 2009-2014, of the 29 million mean annual ED visits by children, 14% (95% confidence interval [CI]: 10%-20%) occurred at pediatric EDs. Antibiotics overall were prescribed more frequently in nonpediatric than pediatric ED visits (24% vs 20%, P < .01). Antibiotic prescribing frequencies were stable over time. Of all antibiotics prescribed, 44% (95% CI: 42%-45%) were broad spectrum, and 32% (95% CI: 30%-34%, 2.1 million per year) were generally not indicated. Compared with pediatric EDs, nonpediatric EDs had a higher frequency of prescribing macrolides (18% vs 8%, P < .0001) and a lower frequency of first-line, guideline-concordant prescribing for the respiratory conditions studied (77% vs 87%, P < .001). CONCLUSIONS: Children are prescribed almost 7 million antibiotic prescriptions in EDs annually, primarily in nonpediatric EDs. Pediatric antibiotic stewardship efforts should expand to nonpediatric EDs nationwide, particularly regarding avoidance of antibiotic prescribing for conditions for which antibiotics are not indicated, reducing macrolide prescriptions, and increasing first-line, guideline-concordant prescribing.
: media-1vid110.1542/5972296744001PEDS-VA_2018-1056Video Abstract OBJECTIVES: To characterize and compare ambulatory antibiotic prescribing for children in US pediatric and nonpediatric emergency departments (EDs). METHODS: A cross-sectional retrospective study of patients aged 0 to 17 years discharged from EDs in the United States was conducted by using the 2009-2014 National Hospital Ambulatory Medical Care Survey ED data. We estimated the proportion of ED visits resulting in antibiotic prescriptions, stratified by antibiotic spectrum, class, diagnosis, and ED type ("pediatric" defined as >75% of visits by patients aged 0-17 years, versus "nonpediatric"). Multivariable logistic regression was used to determine factors independently associated with first-line, guideline-concordant prescribing for acute otitis media, pharyngitis, and sinusitis. RESULTS: In 2009-2014, of the 29 million mean annual ED visits by children, 14% (95% confidence interval [CI]: 10%-20%) occurred at pediatric EDs. Antibiotics overall were prescribed more frequently in nonpediatric than pediatric ED visits (24% vs 20%, P < .01). Antibiotic prescribing frequencies were stable over time. Of all antibiotics prescribed, 44% (95% CI: 42%-45%) were broad spectrum, and 32% (95% CI: 30%-34%, 2.1 million per year) were generally not indicated. Compared with pediatric EDs, nonpediatric EDs had a higher frequency of prescribing macrolides (18% vs 8%, P < .0001) and a lower frequency of first-line, guideline-concordant prescribing for the respiratory conditions studied (77% vs 87%, P < .001). CONCLUSIONS:Children are prescribed almost 7 million antibiotic prescriptions in EDs annually, primarily in nonpediatric EDs. Pediatric antibiotic stewardship efforts should expand to nonpediatric EDs nationwide, particularly regarding avoidance of antibiotic prescribing for conditions for which antibiotics are not indicated, reducing macrolide prescriptions, and increasing first-line, guideline-concordant prescribing.
Authors: Allan S Lieberthal; Aaron E Carroll; Tasnee Chonmaitree; Theodore G Ganiats; Alejandro Hoberman; Mary Anne Jackson; Mark D Joffe; Donald T Miller; Richard M Rosenfeld; Xavier D Sevilla; Richard H Schwartz; Pauline A Thomas; David E Tunkel Journal: Pediatrics Date: 2013-02-25 Impact factor: 7.124
Authors: Guillermo V Sanchez; Daniel J Shapiro; Adam L Hersh; Lauri A Hicks; Katherine E Fleming-Dutra Journal: Open Forum Infect Dis Date: 2017-10-08 Impact factor: 3.835
Authors: Adam L Hersh; Katherine E Fleming-Dutra; Daniel J Shapiro; David Y Hyun; Lauri A Hicks Journal: JAMA Intern Med Date: 2016-12-01 Impact factor: 21.873
Authors: Katherine E Fleming-Dutra; Adam L Hersh; Daniel J Shapiro; Monina Bartoces; Eva A Enns; Thomas M File; Jonathan A Finkelstein; Jeffrey S Gerber; David Y Hyun; Jeffrey A Linder; Ruth Lynfield; David J Margolis; Larissa S May; Daniel Merenstein; Joshua P Metlay; Jason G Newland; Jay F Piccirillo; Rebecca M Roberts; Guillermo V Sanchez; Katie J Suda; Ann Thomas; Teri Moser Woo; Rachel M Zetts; Lauri A Hicks Journal: JAMA Date: 2016-05-03 Impact factor: 56.272
Authors: Madan Dharmar; James P Marcin; Patrick S Romano; Emily R Andrada; Frank Overly; Jonathan H Valente; Danielle J Harvey; Stacey L Cole; Nathan Kuppermann Journal: J Pediatr Date: 2008-07-10 Impact factor: 4.406
Authors: Larissa May; Sara Cosgrove; Michelle L'Archeveque; David A Talan; Perry Payne; Jeanne Jordan; Richard E Rothman Journal: Ann Emerg Med Date: 2012-11-02 Impact factor: 5.721
Authors: Guillermo V Sanchez; Adam L Hersh; Daniel J Shapiro; James F Cawley; Lauri A Hicks Journal: Open Forum Infect Dis Date: 2016-08-10 Impact factor: 3.835
Authors: Mary L Staicu; David Vyles; Erica S Shenoy; Cosby A Stone; Taylor Banks; Kristin S Alvarez; Kimberly G Blumenthal Journal: J Allergy Clin Immunol Pract Date: 2020-10
Authors: Leigh M Howard; Cary Thurm; Keerti Dantuluri; Hannah G Griffith; Sophie E Katz; Michael J Ward; Ritu Banerjee; Carlos G Grijalva Journal: Open Forum Infect Dis Date: 2020-10-22 Impact factor: 3.835
Authors: Liang Dong; Joshua Watson; Sha Cao; Samuel Arregui; Vijay Saxena; John Ketz; Abduselam K Awol; Daniel M Cohen; Jeffrey M Caterino; David S Hains; Andrew L Schwaderer Journal: PLoS One Date: 2020-07-06 Impact factor: 3.240
Authors: Keerti L Dantuluri; Jean Bruce; Kathryn M Edwards; Ritu Banerjee; Hannah Griffith; Leigh M Howard; Carlos G Grijalva Journal: Open Forum Infect Dis Date: 2020-12-15 Impact factor: 4.423